1-(3-aminoindazol-5-yl)-3-butyl-cyclic urea useful as a HIV protease inhibitor
AssigneeBristol-Myers Squibb Pharma Company
InventorsJames D. Rodgers, Patrick Y. Lam
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds of formula I: 1 or pharmaceutically acceptable salt forms or prodrugs thereof, which are useful as inhibitors of HIV protease, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
Claims15
A compound of formula I:
- 8
- or a pharmaceutically acceptable salt or prodrug form thereof.
A method for treating HIV infection which comprises administering to a host in need of such treatment a therapeutically effective amount of a compound of formula I 9
- or a pharmaceutically acceptable salt or prodrug form thereof.
A method of treating HIV infection which comprises administering, in combination, to a host in need thereof a therapeutically effective amount of:
- (a) a compound of formula I 10
- or a pharmaceutically acceptable salt or prodrug form thereof;
- and,
- (b) at least one compound selected from the group consisting of HIV reverse transcriptase inhibitors and HIV protease inhibitors.
Dependencies are inferred from the claim text.